EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Fabrication of Protein Carriers for Intracellular Delivery of Antibiotics Against Intracellular Bacterial Infection

Ting Pan iD, Baozhu Wang, Haojie Du iD, Yuhan Yan, Kai Zhang iD, Cheng Chi, Ronggui Lu, Risheng Li, Yong-Miao Shen iD, Li Hao, Zhijun Zhang

Molecules · 2026

DOI: 10.3390/molecules31132215 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Ting Pan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, School of Chemistry and Chemical Engineering, Zhejiang Sci-Tech University, Hangzhou 310018, China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Drug Carriers, Drug Delivery Systems, Bacterial Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shengzhou Innovation Research Institute of Zhejiang Sci-Tech University, Shaoxing Municipal Science and Technology Bureau, Shaoxing Industry-University-Research Collaborative Research and Development Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial infections pose a serious threat to human health, and antibiotics remain the first-line therapeutic agents in clinical practice. However, the vast majority of antibiotics lack the ability to penetrate cell membranes, which severely limits the number of clinically available options for treating intracellular bacterial infections. Developing efficient intracellular antibiotic delivery strategies is therefore of considerable clinical significance, both for reducing antibiotic dosage and for expanding the repertoire of drugs applicable to intracellular infections. To address this challenge, we constructed a protein-based delivery platform mediated by a cell-penetrating miniprotein for efficient intracellular antibiotic delivery. In this system, bovine serum albumin (BSA), which possesses broad antibiotic-binding capability, was employed as the drug carrier, while the cell-penetrating miniprotein ZF5.3, which is capable of endosomal escape, served as the transmembrane delivery mediator. ZF5.3 was conjugated to BSA via a bioorthogonal reaction, and ceftriaxone (CRO) was selected as the model antibiotic to construct a nanoscale delivery system. The binding interaction between CRO and BSA was characterized using UV-Vis, HPLC, and molecular docking techniques. The assembly of the ZF5.3–BSA delivery platform was confirmed by UV-Vis absorption spectroscopy and gel electrophoresis. Intracellular delivery efficiency was evaluated by confocal fluorescence imaging and flow cytometry, and the results demonstrated that ZF5.3 conjugation enhanced intracellular protein delivery efficiency by over 5-fold. Fluorescence co-localization analysis revealed that ZF5.3-mediated cargo is mainly distributed in the cytoplasm and does not completely co-localize with lysosomal markers, suggesting its ability to effectively escape from lysosomes. An intracellular infection model using Staphylococcus aureus was established. Colony-forming unit (CFU) counting experiments confirmed that the delivery system significantly enhanced the intracellular antibacterial activity of ceftriaxone. CCK8 cytotoxicity assays confirmed that the system is non-toxic to cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsDrug CarriersDrug Delivery SystemsBacterial InfectionsCeftriaxoneSerum Albumin, BovineHumansAnimalsMolecular Docking SimulationCattleMicrobial Sensitivity Tests

Stichwörter der Autor:innen

bovine serum albuminclick chemistryintracellular bacterial infectionintracellular deliveryminiprotein ZF5.3

Substanzen

Anti-Bacterial AgentsSerum Albumin, BovineDrug CarriersCeftriaxone

Autor:innen und Institutionen

  • Department of Chemistry, School of Chemistry and Chemical Engineering, Zhejiang Sci-Tech University, Hangzhou 310018, China.
  • Shengzhou Innovation Research Institute of Zhejiang Sci-Tech University, Shengzhou 312400, China.
  • Zhejiang Dongbang Pharmaceutical Co., Ltd., Linhai 317022, China.

ORCID-Profile: Ting Pan, Haojie Du, Kai Zhang, Yong-Miao Shen

Förderung

  • Shengzhou Innovation Research Institute of Zhejiang Sci-Tech University
  • Shaoxing Municipal Science and Technology Bureau
  • Shaoxing Industry-University-Research Collaborative Research and Development Project
  • Fundamental Research Funds of Shengzhou Innovation Research Institute of Zhejiang Sci-Tech University

Zitieren

APA

Pan, T., Wang, B., Du, H., Yan, Y., Zhang, K., Chi, C., Lu, R., Li, R., Shen, Y. M., Hao, L., & Zhang, Z. (2026). The Fabrication of Protein Carriers for Intracellular Delivery of Antibiotics Against Intracellular Bacterial Infection. Molecules. https://doi.org/10.3390/molecules31132215

Vancouver

Pan T, Wang B, Du H, Yan Y, Zhang K, Chi C, et al. The Fabrication of Protein Carriers for Intracellular Delivery of Antibiotics Against Intracellular Bacterial Infection. Molecules. 2026. doi:10.3390/molecules31132215

BibTeX
@article{Pan2026,
  author = {Pan, Ting and Wang, Baozhu and Du, Haojie and Yan, Yuhan and Zhang, Kai and Chi, Cheng and Lu, Ronggui and Li, Risheng and Shen, Yong-Miao and Hao, Li and Zhang, Zhijun},
  title = {The Fabrication of Protein Carriers for Intracellular Delivery of Antibiotics Against Intracellular Bacterial Infection},
  journal = {Molecules},
  year = {2026},
  doi = {10.3390/molecules31132215}
}
Kostenlos starten →